NCT03906318No Longer Available不适用
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
研究设计
- 研究类型
- Expanded Access
入排标准
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
Available
不适用
Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) DiseaseSTAT1 Gain-of-Function DiseaseNCT05561985Incyte Corporation
Available
不适用
Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)Alopecia AreataNCT05522556Pfizer
尚未招募
4 期
A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAADrug EffectAplastic AnemiaNCT06004791Peking Union Medical College Hospital90
No Longer Available
不适用
Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic CancerNCT03906357Incyte Corporation
Unknown
1 期
Study of Apatinib and MASCT in Patients With Advanced Solid TumorsAdvanced Solid TumorsExcluding T Cell LymphomaNCT02844881The First People's Hospital of Lianyungang60